학술논문

Comparison of outcomes and costs of extracorporeal blood purification therapies in critically ill COVID‐19 patients.
Document Type
Article
Source
Therapeutic Apheresis & Dialysis; Jun2023, Vol. 27 Issue 3, p505-516, 12p
Subject
COVID-19
CYTOKINE release syndrome
CRITICALLY ill
INTENSIVE care units
HEMOPERFUSION
Language
ISSN
17449979
Abstract
Copyright of Therapeutic Apheresis & Dialysis is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)